Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-06-02 20:16 Tx date 2023-05-31 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-27,317,506 vol |
0 | |
Filed 2021-02-18 19:12 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
35,839 | |
Filed 2021-02-18 18:47 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-18 17:40 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
||
Filed 2020-10-21 13:59 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
||
Filed 2021-02-17 21:03 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+1,000,000 vol $0.30 each |
1,035,839 | |
Filed 2021-02-17 21:00 Tx date 2021-01-04 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-900,000 vol |
35,839 | |
Filed 2020-10-21 13:59 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
935,839 | |
Filed 2020-10-21 13:46 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,017
+35,839 vol $0.14 each |
27,317,506 | |
Filed 2020-10-20 13:16 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,017
+35,839 vol $0.14 each |
||
Filed 2020-10-20 13:16 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,017
+35,839 vol $0.14 each |
27,317,506 | |
Filed 2020-10-14 16:16 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-600,000 vol |
0 | |
Filed 2020-10-14 15:56 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
+600,000 vol |
1,200,000 | |
Filed 2020-10-14 15:56 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
+600,000 vol |
||
Filed 2020-10-14 15:38 Tx date 2019-04-12 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+900,000 vol |
2,100,000 | |
Filed 2018-04-16 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
600,000 | |
Filed 2018-04-16 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
||
Filed 2018-04-16 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-28 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+25,090,272 vol |
27,281,667 | |
Filed 2017-11-28 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,030,342 vol |
2,191,395 | |
Filed 2017-11-22 Tx date 2017-10-17 |
$GVE
Gravis Energy Corp. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$66,108
+13,221,737 vol $0.005 each |
13,221,737 | |
Filed 2017-11-22 Tx date 2017-06-21 |
$GVE
Gravis Energy Corp. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|